Are Anuh Pharma latest results good or bad?

Anuh Pharma has released its financial results for the quarter ending March 2025, which reflect a notable performance in certain areas while also highlighting ongoing challenges. The company reported net sales of Rs 198.14 crore, the highest in the last five quarters, and this figure represents a growth of 26.4% compared to the average net sales from the previous four quarters. Additionally, profit before tax (PBT) reached Rs 15.88 crore, indicating a growth of 20.8% over the average PBT from the prior periods. However, the company faced difficulties as profit after tax (PAT) for the latest six months was reported at Rs 22.80 crore, which reflects a decline of 33.86% year on year. This decline raises concerns regarding the sustainability of profitability moving forward. In terms of operational trends, the quarterly results show a growth in net sales of 24.22% compared to the previous quarter, alongside a 20.50% growth in standalone net profit. Operating profit also demonstrated a positive trend, with a growth of 26.39%. It is noteworthy that Anuh Pharma experienced an adjustment in its evaluation over the past three months. Overall, while the company has achieved significant sales growth and improved profit metrics in the latest quarter, the decline in PAT year on year presents a challenge that may impact its future financial stability.